-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$14.67307.5% Upside
Tango Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Wedbush, H.C. Wainwright in the past 90 days.